{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:06:38Z","timestamp":1790856398335,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajt.2026.09.011","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:05:10Z","timestamp":1789052710000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulating cell and xeno-transplants: Learning from medical device oversight"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-2832","authenticated-orcid":false,"given":"Ali B.","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0231-3724","authenticated-orcid":false,"given":"Robert M.","family":"Califf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajt.2026.09.011_bib1","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-021-01144-7","article-title":"Clarifying US regulations on xenotransplantation","volume":"39","author":"Marks","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajt.2026.09.011_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221148771","article-title":"Xenotransplantation: current challenges and emerging solutions","volume":"32","author":"Arabi","year":"2023","journal-title":"Cell Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.09.011_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00005-014-0317-7","article-title":"Immune modulation in xenotransplantation","volume":"63","author":"Boksa","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.ajt.2026.09.011_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899657","article-title":"Progress in xenotransplantation: immunologic barriers, advances in gene editing, and successful tolerance induction strategies in pig-to-primate transplantation","volume":"13","author":"Eisenson","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2026.09.011_bib5","unstructured":"US Food and Drug Administration. Total product life cycle for medical devices. Published online August 24, 2023. Accessed April 10, 2026. https:\/\/www.fda.gov\/about-fda\/cdrh-transparency\/total-product-life-cycle-medical-devices."},{"issue":"19","key":"10.1016\/j.ajt.2026.09.011_bib6","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa2412747","article-title":"Xenotransplantation of a porcine kidney for end-stage kidney disease","volume":"392","author":"Kawai","year":"2025","journal-title":"N Engl J of Med"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.011_bib7","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1038\/s41598-020-66311-3","article-title":"Old World Monkeys are less than ideal transplantation models for testing pig organs lacking three carbohydrate antigens (Triple-Knockout)","volume":"10","author":"Yamamoto","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.011_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12017","article-title":"Limitations of the pig-to-non-human primate islet transplantation model","volume":"20","author":"Wijkstrom","year":"2013","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.ajt.2026.09.011_bib9","series-title":"Current Good Manufacturing Practice (CGMP) regulations","year":"2025"},{"key":"10.1016\/j.ajt.2026.09.011_bib10","series-title":"Quality Management System Regulation (QMSR)","year":"2026"},{"key":"10.1016\/j.ajt.2026.09.011_bib11","series-title":"Predetermined change control plans for medical devices","year":"2024"},{"issue":"7","key":"10.1016\/j.ajt.2026.09.011_bib12","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajt.2026.09.011_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2025.1491568","article-title":"Demise of cadaveric islet transplantation in the USA: Quo Vadis, 1 year after BLA approval and 24 years after the Edmonton breakthrough?","volume":"4","author":"Witkowski","year":"2025","journal-title":"Front Transplant"},{"key":"10.1016\/j.ajt.2026.09.011_bib14","article-title":"Islets transplantation at a crossroads \u2013 need for urgent regulatory update in the United States: perspective presented during the scientific sessions 2021 at the American Diabetes Association Congress","volume":"12","author":"Witkowski","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.ajt.2026.09.011_bib15","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1038\/s41591-024-03241-x","article-title":"Post-approval evidence generation: a shared responsibility for healthcare","volume":"30","author":"Abbasi","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ajt.2026.09.011_bib16","unstructured":"Centers for Medicare & Medicaid Services. Final notice \u2013 transitional coverage for emerging technologies (CMS-3421-FN). Accessed May 10, 2026. https:\/\/www.cms.gov\/newsroom\/fact-sheets\/final-notice-transitional-coverage-emerging-technologies-cms-3421-fn."},{"issue":"7","key":"10.1016\/j.ajt.2026.09.011_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.2017.9414","article-title":"Characteristics of clinical studies used for US Food and Drug Administration approval of high-risk medical device supplements","volume":"318","author":"Zheng","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajt.2026.09.011_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjsurg.2021.08.002","article-title":"The reversal of a \u201creversible\u201d procedure","volume":"223","author":"Abbasi","year":"2022","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.011_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2013.284986","article-title":"FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012","volume":"311","author":"Rome","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajt.2026.09.011_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.7699","article-title":"Risk of recall associated with modifications to high-risk medical devices approved through US Food and Drug Administration supplements","volume":"6","author":"Dubin","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ajt.2026.09.011_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.7274","article-title":"Risk of recall among medical devices undergoing US Food and Drug Administration 510(k) clearance and premarket approval, 2008-2017","volume":"4","author":"Dubin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajt.2026.09.011_bib22","series-title":"Medical device recalls: HHS and FDA should address limitations in oversight of recall process","year":"2025"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526027541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526027541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:17:58Z","timestamp":1790853478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526027541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S1600613526027541"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.09.011","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulating cell and xeno-transplants: Learning from medical device oversight","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}